药物洗脱支架与冠脉搭桥术对老年三支冠脉病变的疗效及费用分析Analysis of effectiveness and cost of drug-eluting stents and Coronary-Artery Bypass Graft for elderly with three-vessel coronary disease
孙宇姣,田文,张海山,贾大林,张月兰,齐国先
摘要(Abstract):
目的比较药物洗脱支架(PCI)与冠状动脉搭桥术(CABG)对老年三支冠脉病变的治疗效果及费用。方法选取2007年4月—2008年11月进行冠脉血运重建的176例三支病变的老年患者(年龄60~79岁),其中PCI组106例,CABG组70例。通过术后6个月和12个月随访比较两组终点事件和治疗费用。结果 PCI组平均住院及术后住院日较CABG组明显缩短(10.77±4.92)d比(46.20±16.19)d,(7.68±4.11)d比(19.51±10.04)d;PCI组完全血运重建率与CABG组相比差异有统计学意义(26.4%比100%,P<0.001)。两次随访两组死亡、心梗及脑卒中发生率无明显差异;PCI组的再血管化治疗高于CABG组(P<0.05);心绞痛及胸闷气短差异无统计学意义(P<0.05);CABG组伤口疼痛发生率显著高于PCI组(P<0.05)。总MACCE事件CABG组虽显著低于PCI组(10.0%比21.7%,P=0.04),但将PCI组中计划内分次进行的血运重建从总MACCE中除去后,两组间差异无统计学意义(P=0.09)。联合终点事件两组间亦差异无统计学意义(P=0.08)。总住院费用及药物费用CABG组显著高于PCI组(P<0.001)。手术费用两者相似(P=0.83)。术后治疗费用PCI组显著高于CABG组(P<0.001)。1年总费用CABG组显著高于PCI组(P<0.001)。两组中完全血运重建者1年费用总和CABG组仍显著高于PCI组(P<0.001)。术后PCI组抗血小板及他汀用药显著优于CABG组。结论对老年三支冠脉病变患者进行药物洗脱支架与冠脉搭桥术的疗效和费用进行综合分析后,提示药物洗脱支架治疗优于冠脉搭桥。
关键词(KeyWords): 冠状动脉疾病;冠状动脉分流术;药物洗脱支架;治疗结果;费用,医疗
基金项目(Foundation):
作者(Author): 孙宇姣,田文,张海山,贾大林,张月兰,齐国先
参考文献(References):
- [1]Flynn M,Reddy S,Shepherd W,et al.Fast-tracking revisited:routine cardiac surgical patients need minimal intensive care.Eur J Cardiothorac Surg,2004,25:116-122.
- [2]Shafiq N,Malhotra S,Pandhi P,et al.A meta-analysis of clinical trial of paclitaxel and sirolimus-eluting stents in patients with obstructive coronary arterydisease.Br J Clin Pharmacol,2005,59:94-101.
- [3]Booth J,Clayton T,Pepper J,et al.Randomized,controlled trial of coronary artery bypass surgery versus percutaneous coronary intervention in patients with multivessel coronary artery disease:six-year follow-up from the Stent or Surgery trial(SOS).Circulation,2008,118:381-388.
- [4]Serruys PW,Morice MC,Kappetein AP,et al.Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease.N Engl J Med,2009,360:961-972.
- [5]Daemen J,Boersma E,Flather M,et al.Long-term safety and efficacy of percutaneous coronary intervention with stenting and coronary artery bypass surgery for multivessel coronary artery disease:a meta-analysis with5-year patient-level data from the ARTS,ERACI-II,MASS-II,and SOS trials.Circulation,2008,118:1146-1154.
- [6]BARI Investigators.The final10-year follow up results from BARI randomized trial.J Am Coll Cardial,2007,49:1600-1606.
- [7]King SB3rd,kosinski AS,Guyton RA,et al.Eight-year mortality in the Emory Angioplasty Versus Surgery Trial(EAST).J Am Coll Cardial,2000,35:1116-1121.
- [8]Kaehler J,Koester R,Billmann W,et al.13-Year follow up ofthe German angioplasty bypass surgery investigation.Eur Heart J,2005,26:2148-2153.
- [9]Henderson RA,Docock SJ,Sharp SJ,et al.Long-term results of RITA-1trial:clinical and cost comparisons of coronary angioplasty and coronary-artery bypass grafting:Randomised Intervention Treatment of Angina.Lancet,1998,352:1419-1425.
- [10]Serruys PW,Ong AT,Morice MC,et al.Arterial Revascularisation Therapies Study part II:Sirolimus-eluting stents for the treatment of patients with multivessel de novo coronary artery lesions.Eurointervention,2005,1:147-156.
- [11]Rodriguez AE,Maree AO,Grinfeld L,et al.Revascularization strategies of coronary multivessel disease in the drug-eluting stent era one year follow-up results of the ERACI-III trial.Eurointervention,2006,2:53-60.
- [12]Serruys PW,Morice MC,Kappetein AP,et al.Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease.N Engl J Med,2009,360:961-972.
- [13]Serruys PW,Unger F,Sousa JE,et al.Comparison of coronary-artery bypass surgery and stenting for the treatment of multivessel disease.N Engl J Med,2001;344:1117-1124.
- [14]Stables R.Coronary artery bypass surgery versus percutaneous coronary intervention with stent implantation in patients with multivessel coronary artery disease(the Stent or Surgery trial):a randomised controlled trial.Lancet,2002;360:965-970.
- [15]Varani E,Balducelli M,Vecchi G,et al.Comparison of multiple drug-eluting stent percutaneous coronary intervention and surgical revasularization in patients with multivessel coronary artery disease:one-year clinical results and total treatment costs.J Invasive Cardiol,2007,19:469-475.
- [16]Bravata DM,Gienger AL,McDonald KM,et al.Systematic review;the comparative effectiveness of percutaneous coronary interventions and coronary artery bypass graft surgery.Ann Intern Med,2007,147:703-716.